Hycamtin
Links shared publicly online about this topic
Hycamtin (Topotecan Hydrochloride) - OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer
oncologyjournal.org — “Hycamtin (Topotecan Hydrochloride) -” View full resource at oncologyjournal.org
Most Recently Shared on December 7, 2009 at 10:50 pm By:
Pacific Oncology Physician Group
Today's cancer drug topic: More about Hycamtin (Topotecan Hydrochloride) http://bit.ly/4WXmoF #cancer #ovarian via @oncologyjournal
Lung cancer: Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial
sciencedaily.com — “Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to new research.” View full resource at sciencedaily.com
Most Recently Shared on July 8, 2011 at 5:20 am By:
Lung cancer: Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial: Lu... http://bit.ly/nU9Aem
Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference
news-medical.net — “Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.” View full resource at news-medical.net
Most Recently Shared on July 7, 2011 at 11:11 am By:
Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference: Lung cancer patients ... http://bit.ly/rhiouc
Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference
news-medical.net — “Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.” View full resource at news-medical.net
Most Recently Shared on July 7, 2011 at 9:34 am By:
Lung Cancer News: Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference: Lun... http://bit.ly/pSH54u
For longtime reporter battling cancer, some setbacks but faith remains strong | jacksonville.com
jacksonville.com — “This year did not start out very well as I launch my third year of fighting small cell lung cancer.A PET scan done Jan. 4 showed numerous small and large masses in the right and left lobes of the liver, an enlarged mass at the head of the pancreas and a right adrenal nodule. Remarkably, there was no cancer in the lungs where the whole mess started.I had completed a sixth course of chemotherapy on Dec. 10 of a drug I really liked, Topotecan, aka Hycamtin. For some reason I felt really good after ” View full resource at jacksonville.com
Most Recently Shared on February 6, 2011 at 6:36 pm By:
For longtime reporter battling cancer, some setbacks but faith remains strong: This year did not start out very ... http://bit.ly/hjaWMs
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Pacific Oncology
A 5 office, community based hematology/oncology group practice serving greater San Diego.
-
Lung Cancer OW
Organizing lung cancer resources shared by health experts, advocates, and organizations into WisdomCards.
-
Lung Cancer OW
Organizing lung cancer resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
